NEW YORK (GenomeWeb News) – Affymetrix's eBioscience business has sold its TrueBlot IP/Western blot product line to Rockland Immunochemicals for an undisclosed price.

The TrueBlot reagents are used in cancer, cell signaling, infectious disease, and other life sciences research to generate data in immunoprecipitation and Western blot experiments. Western blotting is performed to determine expression and quantitate target proteins in biological samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.